Alligator Bioscience appoints Søren Bregenholt as new CEO

19/03/2021

Alligator Bioscience appoints Søren Bregenholt as new CEO Alligator Bioscience (Nasdaq Stockholm: ATORX) today announced that the Board of Directors has appointed Søren Bregenholt, Ph.D. as the company’s new Chief Executive Officer (CEO), to strengthen Alligator’s...

Zealand Pharma completes registration of capital increase

01/02/2021

Zealand Pharma completes registration of capital increase Zealand Pharma A/S announces that it has today, as part of completion of a directed issue and private placement (the “Offering”), registered with the Danish Business Authority, the capital increase...

Alligator Bioscience’s rights issue oversubscribed

27/01/2021

Alligator Bioscience’s rights issue oversubscribed Alligator Bioscience AB (publ) (“Alligator” or the “Company”) has completed the share issue with pre-emption rights for the Company’s shareholders, which was resolved upon by the Board of Directors on December 15,...

Ascelia Pharma gets US patent for 2nd generation Mangoral

15/12/2020

Ascelia Pharma gets US patent for 2nd generation Mangoral Ascelia Pharma AB (publ) (ticker: ACE) today announced that the US Patent Office (USPTO) has issued a new patent covering a second-generation formulation of lead drug candidate Mangoral, currently in the...